Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transdermal beta-blocker therapy in essential hypertension.

C Spieker1, H Vetter, R Liedtke

  • 1Medizinische Universitäts-Poliklinik, Münster, Federal Republic of Germany.

American Journal of Hypertension
|July 1, 1988
PubMed
Summary

Transdermal mepindolol effectively lowered blood pressure in patients with essential hypertension within one week. Further controlled studies comparing transdermal and oral beta-blocker administration are needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Na+ and Mg2+ contents in smooth muscle cells in spontaneously hypertensive rats.

American journal of hypertension·1999
Same author

Studies on diurnal blood pressure variation in kidney diseases associated with excessive salt and water retention.

Journal of human hypertension·1999
Same author

A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group.

Transplantation·1999
Same author

Decreased membrane Mg2+ concentrations in a subgroup of hypertensives: membrane model for the pathogenesis of primary hypertension.

American journal of hypertension·1998
Same author

Increased Na+ and decreased Mg2+ intracellular concentrations in vascular smooth muscle cells from spontaneously hypertensive rats.

Clinical science (London, England : 1979)·1998
Same author

Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension.

Blood pressure. Supplement·1998

Area of Science:

  • Cardiology
  • Pharmacology
  • Dermatology

Background:

  • Transdermal drug delivery aims to reduce administration frequency and improve patient compliance.
  • Essential hypertension management often involves frequent oral medication dosing.

Purpose of the Study:

  • To evaluate the efficacy of transdermal mepindolol for treating essential hypertension.
  • To assess the blood pressure-lowering effects of a novel transdermal beta-blocker system.

Main Methods:

  • Transdermal application of 20 mg mepindolol was administered to patients with essential hypertension.
  • Blood pressure was monitored to assess the antihypertensive effect of the transdermal beta-blocker.

Main Results:

  • Transdermal mepindolol demonstrated a significant blood pressure lowering effect within one week.

Related Experiment Videos

  • Initial systolic and diastolic blood pressure readings were significantly reduced post-treatment (P < 0.05).

    • Conclusions:

    • Transdermal mepindolol is a potentially effective treatment for essential hypertension.
    • Further controlled trials comparing transdermal and oral beta-blocker administration are warranted before clinical adoption.